J&J's Revamped R&D Will Release First Drug In 2004, Diabetic Likely Choice

Johnson & Johnson's re-engineered research and development program will release its first product in 2004, most likely in the diabetes area, R&D Pharmaceuticals Chairman Per Peterson, MD/PhD, indicated.

More from Archive

More from Pink Sheet